Response to: 'Correspondence on 'Preliminary predictive criteria for COVID-19 cytokine storm'' by Tampe et al
- PMID: 33414184
- DOI: 10.1136/annrheumdis-2020-219720
Response to: 'Correspondence on 'Preliminary predictive criteria for COVID-19 cytokine storm'' by Tampe et al
Keywords: COVID-19; health care; inflammation; outcome assessment.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Preliminary predictive criteria for COVID-19 cytokine storm.Ann Rheum Dis. 2021 Jan;80(1):88-95. doi: 10.1136/annrheumdis-2020-218323. Epub 2020 Sep 25. Ann Rheum Dis. 2021. PMID: 32978237 Review.
-
Correspondence on 'Preliminary predictive criteria for COVID-19 cytokine storm'.Ann Rheum Dis. 2023 Mar;82(3):e71. doi: 10.1136/annrheumdis-2020-219709. Epub 2021 Jan 7. Ann Rheum Dis. 2023. PMID: 33414185 No abstract available.
Similar articles
-
Correspondence on 'Preliminary predictive criteria for COVID-19 cytokine storm'.Ann Rheum Dis. 2023 Mar;82(3):e71. doi: 10.1136/annrheumdis-2020-219709. Epub 2021 Jan 7. Ann Rheum Dis. 2023. PMID: 33414185 No abstract available.
-
An Unusual Case of Severe Pneumocystis Jiroveci Pneumonia (PJP) presenting as "Recurrent Cytokine Storm'' following COVID-19 Infection.J Assoc Physicians India. 2021 May;69(5):78. J Assoc Physicians India. 2021. PMID: 34189894 No abstract available.
-
Comment on Hu et al: The cytokine storm and COVID-19.J Med Virol. 2021 Feb;93(2):631-633. doi: 10.1002/jmv.26396. Epub 2020 Aug 21. J Med Virol. 2021. PMID: 32761905 Free PMC article. No abstract available.
-
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.Rev Recent Clin Trials. 2021;16(2):138-145. doi: 10.2174/1574887115666200917110954. Rev Recent Clin Trials. 2021. PMID: 32940187 Review.
-
Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm.Biomolecules. 2021 Jan 12;11(1):91. doi: 10.3390/biom11010091. Biomolecules. 2021. PMID: 33445810 Free PMC article. Review.
Cited by
-
The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19.Int Immunopharmacol. 2021 Dec;101(Pt B):108255. doi: 10.1016/j.intimp.2021.108255. Epub 2021 Oct 15. Int Immunopharmacol. 2021. PMID: 34688149 Free PMC article. Review.
-
Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome.Cell Rep Med. 2021 May 18;2(5):100269. doi: 10.1016/j.xcrm.2021.100269. Epub 2021 Apr 19. Cell Rep Med. 2021. PMID: 33899032 Free PMC article.
-
Editorial: Multidisciplinary critical care medicine - Getting things done across specialties.Front Med (Lausanne). 2023 Jan 18;10:1135003. doi: 10.3389/fmed.2023.1135003. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36744137 Free PMC article. No abstract available.
-
Hemophagocytic histiocytosis in severe SARS-CoV-2 infection: A bone marrow study.Int J Lab Hematol. 2021 Dec;43(6):1291-1301. doi: 10.1111/ijlh.13619. Epub 2021 Jun 4. Int J Lab Hematol. 2021. PMID: 34086418 Free PMC article.
-
Early prediction of in-hospital death of COVID-19 patients: a machine-learning model based on age, blood analyses, and chest x-ray score.Elife. 2021 Oct 18;10:e70640. doi: 10.7554/eLife.70640. Elife. 2021. PMID: 34661530 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical